Results 121 to 130 of about 5,071,260 (360)

Targeting the AKT/mTOR pathway attenuates the metastatic potential of colorectal carcinoma circulating tumor cells in a murine xenotransplantation model

open access: yesMolecular Oncology, EarlyView.
Dual targeting of AKT and mTOR using MK2206 and RAD001 reduces tumor burden in an intracardiac colon cancer circulating tumor cell xenotransplantation model. Analysis of AKT isoform‐specific knockdowns in CTC‐MCC‐41 reveals differentially regulated proteins and phospho‐proteins by liquid chromatography coupled mass spectrometry. Circulating tumor cells
Daniel J. Smit   +19 more
wiley   +1 more source

Electrochemical reactor with carbon membrane electrodes for efficient phenol removal via anode and cathode synergism

open access: yesnpj Clean Water
Current electrochemical membrane reactors (EMRs) focus on half-cell reactions, which limits their efficiency. Herein, an EMR-P with full-cell reactions was constructed using a carbon membrane (CM) as the cathode and a TiO2-loaded CM as the anode ...
Zishang Chen   +6 more
doaj   +1 more source

Time, the final frontier

open access: yesMolecular Oncology, EarlyView.
This article advocates integrating temporal dynamics into cancer research. Rather than relying on static snapshots, researchers should increasingly consider adopting dynamic methods—such as live imaging, temporal omics, and liquid biopsies—to track how tumors evolve over time.
Gautier Follain   +3 more
wiley   +1 more source

Membrane fluidity and membrane fusion [PDF]

open access: yesBiochemical Journal, 1972
Q F Ahkong   +5 more
openaire   +3 more sources

Techno-economic process optimization for a range of membrane performances: What provides real value for point-source carbon capture?

open access: yesCarbon Capture Science & Technology
Membranes provide a unique opportunity for heavy industry decarbonization and a real solution requires optimal system design. We use a superstructure process model to minimize capital and operational expenses for post-combustion carbon capture systems ...
Joshua C. Watson   +3 more
doaj  

Inhibitor of DNA binding‐1 is a key regulator of cancer cell vasculogenic mimicry

open access: yesMolecular Oncology, EarlyView.
Elevated expression of transcriptional regulator inhibitor of DNA binding 1 (ID1) promoted cancer cell‐mediated vasculogenic mimicry (VM) through regulation of pro‐angiogenic and pro‐cancerous genes (e.g. VE‐cadherin (CDH5), TIE2, MMP9, DKK1). Higher ID1 expression also increased metastases to the lung and the liver.
Emma J. Thompson   +11 more
wiley   +1 more source

Home - About - Disclaimer - Privacy